Regulation of Local Angiotensin II Formation in the Human Heart in the Presence of Interstitial Fluid
- 18 March 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 95 (6) , 1455-1463
- https://doi.org/10.1161/01.cir.95.6.1455
Abstract
BackgroundData from in vitro studies suggest that both chymase and ACE contribute to the local generation of angiotensin (Ang) II in the heart. The enzyme kinetics under in vivo conditions are unclear. We thus studied the generation of Ang II by cardiac tissue in the presence of interstitial fluid (IF) that contains a variety of naturally occurring protease inhibitors.Methods and ResultsAng I was incubated with heart homogenate in the presence of IF. IF obtained from human skin contained substantial amounts of protease inhibitors and ACE activity, the concentration of α1-antitrypsin being 35% and the activity of ACE 24% of the corresponding serum values. When heart homogenate was incubated with Ang I, three enzymes were responsible for its metabolism: heart chymase and heart ACE converted Ang I to Ang II, and heart carboxypeptidase A (CPA)–like activity degraded Ang I to Ang-(1-9). Incubation of heart homogenate in the presence of IF led to practically full inhibition of heart chymase–mediated Ang II formation by the natural protease inhibitors present in IF. In contrast, heart CPA–like activity was not blocked, as reflected by the continued generation of Ang-(1-9). In addition, both heart ACE– and IF ACE–mediated Ang II formation were strongly inhibited. This inhibition was shown to be due to the Ang-(1-9) formed.ConclusionsThe present experimental study defines two novel inhibitory mechanisms of Ang II formation in the human heart interstitium. Heart chymase–mediated Ang II formation is strongly inhibited by the natural protease inhibitors present in the IF. Similarly, both heart ACE– and IF ACE–mediated Ang II formation appear to be inhibited by the endogenous inhibitor Ang-(1-9) formed by heart CPA–like activity. These inhibitory mechanisms provide additional information about how the Ang II concentration in the heart interstitium may be controlled.Keywords
This publication has 17 references indexed in Scilit:
- Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems.Journal of Clinical Investigation, 1995
- Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.Journal of Clinical Investigation, 1995
- Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.Hypertension, 1991
- Endogenous inhibitor of angiotensin converting enzyme in the rat heartBiochemical and Biophysical Research Communications, 1989
- Inhibition of angiotensin-converting enzyme by des-Leu10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme regulationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Substrate specificity and kinetic characteristics of angiotensin converting enzymeBiochemistry, 1983
- Identification of a human neutrophil angiotension II-generating protease as cathepsin G.Journal of Clinical Investigation, 1982
- Biochemical Composition of Suction Blister Fluid Determined by High Resolution Multicomponent Analysis (Capillary Gas Chromatography—Mass Spectrometry and Two-Dimensional Electrophoresis)Journal of Investigative Dermatology, 1980
- Design of new antihypertensive drugs: Potent and specific inhibitors of angiotensin-converting enzymeProgress in Cardiovascular Diseases, 1978
- Dermo-Epidermal Separation with SuctionJournal of Investigative Dermatology, 1967